Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.188,94
0,02%
NASDAQ
16.298,21
-0,21%
Bitcoin
62.274,99
-0,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cyteir Therapeutics Inc (CYT) Cyteir Therapeutics Inc (CYT) Notizie

Cyteir Therapeutics Inc

CYT
3,02
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202422:31EDGAR2Form 8-K - Current report
07/3/202422:30BWCyteir Announces Timeline for Voluntarily Delisting from..
06/3/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202401:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202322:00EDGAR2Form 8-K - Current report
14/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:05EDGAR2Form 8-K - Current report
22/11/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:01EDGAR2Form 8-K - Current report
06/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202322:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
12/10/202313:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/10/202313:51EDGAR2Form 8-K - Current report
12/10/202313:30BWOngoing Results From a Dose Expansion Cohort of CYT-0851 in..
05/10/202322:00EDGAR2Form 8-K - Current report
02/10/202322:44EDGAR2Form PREM14A - Preliminary proxy statements relating to..
07/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/6/202323:29EDGAR2Form 144 - Report of proposed sale of securities
30/6/202316:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/6/202316:22EDGAR2Form 8-K - Current report
30/6/202314:00BWCyteir Therapeutics Announces Discontinuation of CYT-0851..
03/6/202315:00BWPreliminary Ongoing Results with CYT-0851 in Combination..
10/5/202322:01BWCyteir Therapeutics Reports First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 3,02

La tua Cronologia

NASDAQ
CYT
Cyteir Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network